Skip to main content
Caplight Logo









CytoHub Inc.

CytoHub Inc.

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://cytohub.com/

Last Round

VC Round

Dec 1, 2025

Company Overview

CytoHub Inc. is a biotechnology company that develops AI-powered platforms and intelligent technologies for cell therapy and regenerative medicine, with a focus on cardiac health.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Infrastructure

Keywords

regenerative medicinecell therapydrug discoveryorganoid modelshuman induced pluripotent stem cellhiPSCcomputational biologybiomanufacturingdigital twinsin vitro testingdisease modelingpredictive pharmacologybiotech platformorgan-on-a-chiplab-on-a-chipAI-driven drug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CytoHub Inc. Comparables

Compare CytoHub Inc. with similar companies based on industry and business-model similarity.

CytoHub Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
HeartBeat.bio AG
86%
Axol Bioscience
80%
Genome Biologics
78%

CytoHub Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundDec 1, 2025
SeedMar 13, 2025

Key People

Founding team and executive leadership

Rajib Biswas

Chief Executive Officer & Co-Founder, Chairman of the Board

Founding Team

CytoHub Inc. Investors

Notable investors and investment history

CytoHub Inc. investors
InvestorRounds
Michigan Rise and Red Cedar VenturesVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 21, 2025

    Grew 30% QoQ, from 10 to 13 employees.

  • Jun 1, 2025

    Monthly visitors increased 60% MoM.

CytoHub Inc. Filings

Explore SEC and related filing metadata, where available.

CytoHub Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about CytoHub Inc.'s valuation, stock price, and market status.

Is CytoHub Inc. a public or private company?

CytoHub Inc. is a private company.

What is the current stock price of CytoHub Inc.?

CytoHub Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is CytoHub Inc. worth (valuation)?

Valuation information for CytoHub Inc. is not publicly available.

Can I buy CytoHub Inc. stock?

CytoHub Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was CytoHub Inc.'s last funding round?

CytoHub Inc.'s most recent funding round was VC Round on December 1, 2025.

Who are the main investors in CytoHub Inc.?

Key investors in CytoHub Inc. include Michigan Rise and Red Cedar Ventures.

Will CytoHub Inc. IPO soon?

No public IPO plans have been announced for CytoHub Inc..

How can I track CytoHub Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CytoHub Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Diego, California
Employee Range12
Year Founded2023
Last FundingDec 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?